Shmagin Martin E 4
4 · Urigen Pharmaceuticals, Inc. · Filed Feb 3, 2009
Insider Transaction Report
Form 4
Urigen Pharmaceuticals, Inc.UGRP.OB
Shmagin Martin E
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock, $.001 Par Value
2009-01-29$0.13/sh+1,000$130→ 3,119,573 total - Purchase
Common Stock, $.001 Par Value
2009-01-29$0.10/sh+3,000$300→ 3,122,573 total